KW KOSEF KQ 150 FTR Inverse ETF (291620)
KRX SM KRX SM Primary Summary
291620 Chart
KW KOSEF KQ 150 FTR Inverse ETF (291620) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has KW KOSEF KQ 150 FTR Inverse ETF ever had a stock split?
KW KOSEF KQ 150 FTR Inverse ETF Profile
| KRX SM Exchange | Poland Country |
Overview
Celon Pharma S.A. is an integrated pharmaceutical company based in Lomianki, Poland. Founded in 2002, the company specializes in the research, manufacture, and marketing of pharmaceutical products and preparations. With a strategic focus on developing treatments for a range of diseases, Celon Pharma S.A. leverages its expertise in pharmaceutical research to contribute to advances in healthcare. Operating as a subsidiary of Glatton Sp. z o.o., Celon Pharma has established itself as a key player in the pharmaceutical industry, especially in the areas of oncology, neurology, diabetes, and metabolic disorders. The company's commitment to innovation and quality ensures it remains at the forefront of developing effective solutions for global health challenges.
Products and Services
- Cancer Treatments:
Celon Pharma S.A. develops and markets a range of pharmaceutical products aimed at treating various types of cancers. Utilizing cutting-edge research and technology, the company’s offerings in this area include innovative therapies that target cancer cells while minimizing side effects, thereby improving patients' quality of life and survival rates.
- Neurological Disease Therapies:
The company offers drugs designed to address a variety of neurological conditions, including but not limited to Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These treatments are the result of intensive research and development efforts aimed at understanding neurological pathologies and finding effective ways to treat them, enhancing patients' neurological function and slowing disease progression.
- Diabetes and Other Metabolic Disorder Treatments:
Celon Pharma S.A. also produces medications for the management and treatment of diabetes and other metabolic disorders. By focusing on the regulation of metabolism and the maintenance of blood sugar levels, these drugs play a crucial role in managing the symptoms and complications associated with these conditions, contributing to the overall well-being of patients.
